Literature DB >> 6846084

Treatment of hypertension with labetalol in neurosurgical practice. Influence of labetalol on cerebral perfusion pressure in dogs without and with intracranial mass lesions.

C Puchstein, H van Aken, J Hidding, C Anger, P Lawin.   

Abstract

In neurosurgical patients autoregulation of cerebral perfusion is often lost. Therefore, a sudden increase in blood pressure may lead to an increase in cerebral blood flow and cerebral oedema may follow. The influence of labetalol, a new alpha- and beta-adrenoceptor blocking agent, on intracranial pressure and cerebral perfusion pressure was investigated in dogs without and with mass lesions. During hypotension with labetalol the intracranial pressure remained unchanged and the cerebral perfusion pressure decreased to the same extent as mean arterial pressure (30%). Labetalol seems to be suitable to treat hypertension perioperatively in neurosurgical patients but it is not a suitable drug for induced hypotension.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6846084     DOI: 10.1007/bf01401430

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  25 in total

1.  Circulatory changes during direct laryngoscopy and tracheal intubation: influence of duration of laryngoscopy with or without prior lidocaine.

Authors:  R K Stoelting
Journal:  Anesthesiology       Date:  1977-10       Impact factor: 7.892

2.  The sympathetic nervous system and the regulation of cerebral blood flow in man.

Authors:  E Skinhoj
Journal:  Stroke       Date:  1972 Nov-Dec       Impact factor: 7.914

3.  Proceedings: Changes in intracranial pressure and systemic arterial pressure during the termination of anaesthesia.

Authors:  P Leech; J Barker; W Fitch
Journal:  Br J Anaesth       Date:  1974-04       Impact factor: 9.166

4.  Regional cerebral blood flow in patients with intracranial tumors.

Authors:  R Pálvölgyi
Journal:  J Neurosurg       Date:  1969-08       Impact factor: 5.115

5.  Derangement of regional cerebral blood flow and of its regulatory mechanisms in acute cerebrovascular lesions.

Authors:  C Fieschi; A Agnoli; N Battistini; L Bozzao; M Prencipe
Journal:  Neurology       Date:  1968-12       Impact factor: 9.910

Review 6.  Clinical pharmacology of labetalol.

Authors:  D A Richards; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

7.  The prevention of hypertension at intubation.

Authors:  H Van Aken; C Puchstein; J Hidding
Journal:  Anaesthesia       Date:  1982-01       Impact factor: 6.955

8.  Intracranial pressure changes in neurosurgical patients during hypotension induced with sodium nitroprusside or trimetaphan.

Authors:  J M Turner; D Powell; R M Gibson; D G McDowall
Journal:  Br J Anaesth       Date:  1977-05       Impact factor: 9.166

9.  Use of labetalol during hypotensive anaesthesia and in the management of phaeochromocytoma.

Authors:  L Kaufman
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

10.  Labetalol in controlled hypotension: administration of labetalol when adequate hypotension is difficult to achieve.

Authors:  D H Cope; M C Crawford
Journal:  Br J Anaesth       Date:  1979-04       Impact factor: 9.166

View more
  1 in total

1.  Retrospective evaluation of labetalol as antihypertensive agent in dogs.

Authors:  Francesco Zublena; Chiara De Gennaro; Federico Corletto
Journal:  BMC Vet Res       Date:  2020-07-24       Impact factor: 2.741

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.